Results 171 to 180 of about 757,873 (207)
Some of the next articles are maybe not open access.
Trends in Cardiovascular Medicine, 2023
Cardiac sarcoidosis is an inflammatory myocardial disease of unknown etiology. It is characterized by the deposition of non-caseating granulomas that may involve any part of the heart. Cardiac sarcoidosis is often under-diagnosed or recognized partly due to the heterogeneous clinical presentation of the disease.
Jian Liang Tan, Bryan E-Xin Tan
exaly +3 more sources
Cardiac sarcoidosis is an inflammatory myocardial disease of unknown etiology. It is characterized by the deposition of non-caseating granulomas that may involve any part of the heart. Cardiac sarcoidosis is often under-diagnosed or recognized partly due to the heterogeneous clinical presentation of the disease.
Jian Liang Tan, Bryan E-Xin Tan
exaly +3 more sources
Seminars in Respiratory and Critical Care Medicine, 2010
Cardiac involvement is undeniably one of the most challenging issues in sarcoidosis. Although autopsy studies reveal heart lesions in 20 to 30% of sarcoid patients, fewer than 5% suffer from clinical disease. Cardiac sarcoidosis (CS) has a predilection for the myocardium, but the pericardium and endocardium may also be affected.
Hilario, Nunes +7 more
openaire +4 more sources
Cardiac involvement is undeniably one of the most challenging issues in sarcoidosis. Although autopsy studies reveal heart lesions in 20 to 30% of sarcoid patients, fewer than 5% suffer from clinical disease. Cardiac sarcoidosis (CS) has a predilection for the myocardium, but the pericardium and endocardium may also be affected.
Hilario, Nunes +7 more
openaire +4 more sources
Current Cardiology Reports, 2014
Cardiac sarcoidosis (CS) is a rare and under-recognized clinical entity that requires a high level of suspicion and low threshold for screening in order to make the diagnosis. CS may manifest in a variety of ways, and its initial presentation can range from asymptomatic electrocardiographic abnormalities to overt heart failure to sudden cardiac death ...
Matthew M, Zipse, William H, Sauer
openaire +2 more sources
Cardiac sarcoidosis (CS) is a rare and under-recognized clinical entity that requires a high level of suspicion and low threshold for screening in order to make the diagnosis. CS may manifest in a variety of ways, and its initial presentation can range from asymptomatic electrocardiographic abnormalities to overt heart failure to sudden cardiac death ...
Matthew M, Zipse, William H, Sauer
openaire +2 more sources
Arrhythmia in Cardiac Sarcoidosis
Cardiology in Review, 2020Cardiac sarcoidosis (CS) is a complex disease that can manifest as a diverse array of arrhythmias. CS patients may be at higher risk for sudden cardiac death (SCD), and, in some cases, SCD may be the first presenting symptom of the underlying disease. As such, identification, risk stratification, and management of CS-related arrhythmia are crucial in ...
Andrew H, Locke +4 more
openaire +2 more sources
La Presse Médicale, 2012
The prognosis of sarcoidosis often considered as "benign" is significantly changed in the presence of a cardiac localization. An in-depth interview, a clinical examination together with ECG are often for most of sarcoidosis. Certain conditions (severe multisystemic sarcoidosis, rares localizations in particular neurological, renal, gastric) lead to ...
openaire +5 more sources
The prognosis of sarcoidosis often considered as "benign" is significantly changed in the presence of a cardiac localization. An in-depth interview, a clinical examination together with ECG are often for most of sarcoidosis. Certain conditions (severe multisystemic sarcoidosis, rares localizations in particular neurological, renal, gastric) lead to ...
openaire +5 more sources
Cardiac Involvement in Sarcoidosis
Seminars in Respiratory and Critical Care Medicine, 2002Cardiac sarcoidosis is a challenging diagnostic entity. Manifestations range from an incidentally discovered, benign condition to fatal cardiomyopathy and arrhythmias. In this review, we discuss the salient clinical features, diagnostic evaluation, treatment, and prognosis of cardiac sarcoidosis.
Jane C, Deng +2 more
openaire +2 more sources
Annals of the American Thoracic Society, 2019
Abstract Increasing awareness of cardiac manifestations of sarcoidosis and the widespread availability of advanced imaging tests have led to a tidal wave of interest in a condition that was once considered rare. In this Focused Review, we explore important clinical questions that may confront specialists faced with possible cardiac ...
Manuel L, Ribeiro Neto +5 more
openaire +2 more sources
Abstract Increasing awareness of cardiac manifestations of sarcoidosis and the widespread availability of advanced imaging tests have led to a tidal wave of interest in a condition that was once considered rare. In this Focused Review, we explore important clinical questions that may confront specialists faced with possible cardiac ...
Manuel L, Ribeiro Neto +5 more
openaire +2 more sources
Cardiac Arrhythmias in Sarcoidosis
Archives of Internal Medicine, 1964Since myocardial sarcoidosis was described in 1929, 1 there have been reported to date some 35 cases in which death was due directly to this manifestation of the disease. 2,3 In over 50% of these cases death was sudden, and often the existence of myocardial lesions had not been suspected clinically. Because of the paucity of antemortem case studies in
A W, NISSEN, J B, BERTE
openaire +2 more sources
Treatment of cardiac sarcoidosis
Current Opinion in Pulmonary Medicine, 2019In sarcoidosis, the appropriate management strategy remains challenging especially because of the lack of confident diagnosis, considerable variability in initial presentation, disease evolution, and outcome. Although asymptomatic patients with limited cardiac involvement have been described to have a benign outcome, cardiac sarcoidosis is associated ...
Vasileios, Kouranos +2 more
openaire +2 more sources
Current Opinion in Pulmonary Medicine, 2017
To address the current recommendations for screening, diagnosis, and treatment of cardiac sarcoidosis and the difficulties to put these recommendations into clinical practice.The incidence of cardiac sarcoidosis appears to be higher than earlier reported, probably because of improved imaging techniques. Late gadolinium enhancement with cardiac MRI (LGE-
Bakker, Anne L +3 more
openaire +4 more sources
To address the current recommendations for screening, diagnosis, and treatment of cardiac sarcoidosis and the difficulties to put these recommendations into clinical practice.The incidence of cardiac sarcoidosis appears to be higher than earlier reported, probably because of improved imaging techniques. Late gadolinium enhancement with cardiac MRI (LGE-
Bakker, Anne L +3 more
openaire +4 more sources